Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 October 2022 | Story Valentino Ndaba | Photo Valentino Ndaba
World Mental Health Day
The UFS community, in partnership with various stakeholders, commemorated World Mental Health Day on 10 October 2022.

About 400 million people globally suffer from mental or neurological disorders and psychosocial problems. Mental disorders, much like physical ones, differ in severity. The Department of Health distinguishes between transient (such as an acute stress disorder), periodic (such as bipolar disorder, characterised by periods of exaggerated elation followed by periods of depression), and long-lasting and progressive (such as Alzheimer’s disease) disorders.

Mental health issues such as depression, anxiety, substance abuse, and job stress are the most common conditions. It is not only the individuals suffering from these problems who are affected, but also their families, co-workers, and the broader community. An interplay between biological, psychological, social, and environmental factors results in mental health conditions.

Mobilising efforts in support of mental health
Internationally, the month of October has been declared Mental Health Awareness Month, with 10 October being the day on which Mental Health Day is observed. The objective is to educate the public about mental health and to reduce the stigma that people with mental illness are often subjected to. To mark the day, the University of the Free State (UFS) Student Counselling and Development (SCD) Office, KovsieHealth, and the student mental health advocacy organisation, Next Chapter, held an activation at the Thakaneng Bridge on the Bloemfontein Campus. This followed a silent walk from the campus’ main gate to the bridge.

Chairperson of Next Chapter, Lehlogonolo Sebjetseba, emphasised the significance of commemorating Mental Health Day. “The importance of observing this day is to continue raising awareness about mental health and to further reduce the stigma around mental health. We did this by introducing students to different psychosocial support organisations such as Alnisa Continua, Panda, the Befrienders, and more. These organisations cater specifically for students’ mental well-being,” said the second-year Industrial Psychology student.

Raise awareness of mental health issues
On 12 October 2022, the Division of Organisational Development and Employee Well-Being, together with the Department of Human Resources (HR), presented a Mental Health talk by award-winning journalist and author, Marion Scher, on the Bloemfontein Campus. The talk touched on preventive mental health interventions, breaking the silence around mental health issues, and guidelines on how to provide support to those affected by mental health problems.

Scher further explained bipolar disorder and schizophrenia, as well as the difference between a bad day and clinical depression. Guidance was provided on avenues to explore when seeking mental health assistance, and advice was offered on what to do if you think someone is having suicidal ideation. In addition, the division has made available the Mental Health Awareness Month Toolkit, which employees can access for free online.

Mental health is a global priority
The overall objective of World Mental Health Day is to raise awareness of mental health issues around the world. This year’s national theme is ‘Mental Health and Well-being for All: Promoting Mental Health in Physical and Virtual Spaces’, which is based on the global theme: ‘Making Mental Health and Well-Being for All a Global Priority’. This is in line with Sustainable Development Goal number three, which focuses on good health and well-being.

SCD and HR will continue to host events throughout the year that encourage students and staff to protect and improve their mental health. These are some of the upcoming events:

Health Survival Guide webinar (students):
Date: 21 October 2022
Time: 10:00
Venue: Blackboard

Self-care webinar (students):
Date: 1 November 2022
Time: 12:00-14:00
Venue: Blackboard

 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept